Paper17575106
Wnt3/RhoA/ROCK signaling pathway is involved in adhesion-mediated drug resistance of multiple myeloma in an autocrine mechanism.
Kobune M and 10 others. Mol Cancer Ther, 2007. Cited by 80 papers, by iCite.
Cite this record
ConductScience Library. Wnt3/RhoA/ROCK signaling pathway is involved in adhesion-mediated drug resistance of multiple myeloma in an autocrine mechanism. Papers, record 17575106. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17575106
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Wnt3/RhoA/ROCK signaling pathway is involved in adhesion-mediated drug resistance of multiple myeloma in an autocrine mechanism.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Adhesion | Major topic |
| Drug Resistance, Neoplasm | Major topic |
| Intracellular Signaling Peptides and Proteins | Major topic |
| Multiple Myeloma | Major topic |
| Protein Serine-Threonine Kinases | Major topic |
| Signal Transduction | Major topic |
| Wnt Proteins | Major topic |
| rhoA GTP-Binding Protein | Major topic |
| Base Sequence | |
| Cell Line, Tumor | |
| DNA Primers | |
| Humans | |
| Vinculin | |
| Wnt3 Protein | |
| rho-Associated Kinases |
Source PubMed
Cited by53
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42667654 | B cell mechanisms underlie IgG glycan alterations in obesity. | Glycobiology | 2026 | https://conductscience.org/library/papers/42667654 | PubMed |
| 41933134 | The role of Rho-associated coiled-coil kinases (ROCK) in cancer. | Oncogene | 2026 | https://conductscience.org/library/papers/41933134 | PubMed |
| 41928953 | Spatial multi-omics of multiple myeloma uncovers niche-dependent pro-myeloma and immunosuppressive signaling in the bone marrow and extramedullary lesions. | bioRxiv | 2026 | https://conductscience.org/library/papers/41928953 | PubMed |
| 40650009 | Expression of WNT Family Genes in Mesenchymal Stromal Cells of the Hematopoietic Niche in Patients with Different Responses to Multiple Myeloma Treatment. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40650009 | PubMed |
| 40227962 | Ubiquitination of transcription factors in cancer: unveiling therapeutic potential. | Mol Oncol | 2025 | https://conductscience.org/library/papers/40227962 | PubMed |
| 39402585 | RhoA-ROCK2 signaling possesses complex pathophysiological functions in cancer progression and shows promising therapeutic potential. | Cancer Cell Int | 2024 | https://conductscience.org/library/papers/39402585 | PubMed |
| 39021902 | Pathways to therapy resistance: The sheltering effect of the bone marrow microenvironment to multiple myeloma cells. | Heliyon | 2024 | https://conductscience.org/library/papers/39021902 | PubMed |
| 38711026 | WNT3 promotes chemoresistance to 5-Fluorouracil in oral squamous cell carcinoma via activating the canonical β-catenin pathway. | BMC Cancer | 2024 | https://conductscience.org/library/papers/38711026 | PubMed |
| 37239457 | Transcription of WNT Genes in Hematopoietic Niche's Mesenchymal Stem Cells in Multiple Myeloma Patients with Different Responses to Treatment. | Genes (Basel) | 2023 | https://conductscience.org/library/papers/37239457 | PubMed |
| 36986514 | Past, Present, and a Glance into the Future of Multiple Myeloma Treatment. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/36986514 | PubMed |
| 35069211 | USP14: Structure, Function, and Target Inhibition. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/35069211 | PubMed |
| 34979567 | SORT1/LAMP2-mediated extracellular vesicle secretion and cell adhesion are linked to lenalidomide resistance in multiple myeloma. | Blood Adv | 2022 | https://conductscience.org/library/papers/34979567 | PubMed |
| 34439223 | Investigating the Interplay between Myeloma Cells and Bone Marrow Stromal Cells in the Development of Drug Resistance: Dissecting the Role of Epigenetic Modifications. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34439223 | PubMed |
| 34433809 | Reelin depletion alleviates multiple myeloma bone disease by promoting osteogenesis and inhibiting osteolysis. | Cell Death Discov | 2021 | https://conductscience.org/library/papers/34433809 | PubMed |
| 34295898 | CAM-DR: Mechanisms, Roles and Clinical Application in Tumors. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34295898 | PubMed |
| 34145309 | Next generation proteomics with drug sensitivity screening identifies sub-clones informing therapeutic and drug development strategies for multiple myeloma patients. | Sci Rep | 2021 | https://conductscience.org/library/papers/34145309 | PubMed |
| 33918655 | Role and Therapeutic Targeting of SDF-1α/CXCR4 Axis in Multiple Myeloma. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33918655 | PubMed |
| 33806209 | Management of Myeloma Bone Lesions. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33806209 | PubMed |
| 32429518 | Reduction of Secreted Frizzled-Related Protein 5 Drives Vascular Calcification through Wnt3a-Mediated Rho/ROCK/JNK Signaling in Chronic Kidney Disease. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32429518 | PubMed |
| 31921125 | WNT Signaling in Tumors: The Way to Evade Drugs and Immunity. | Front Immunol | 2019 | https://conductscience.org/library/papers/31921125 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CTNNB1 | 1499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| DKK1 | 22943 | PubTator's text mining | https://conductscience.org/library/genes/22943 | NCBI Gene |
| FRZB | 2487 | PubTator's text mining | https://conductscience.org/library/genes/2487 | NCBI Gene |
| FZD1 | 8321 | PubTator's text mining | https://conductscience.org/library/genes/8321 | NCBI Gene |
| IGKV7-3 | 28905 | PubTator's text mining | https://conductscience.org/library/genes/28905 | NCBI Gene |
| ITGA6 | 3655 | PubTator's text mining | https://conductscience.org/library/genes/3655 | NCBI Gene |
| ITGB1 | 3688 | PubTator's text mining | https://conductscience.org/library/genes/3688 | NCBI Gene |
| RHOA | 387 | PubTator's text mining | https://conductscience.org/library/genes/387 | NCBI Gene |
| WNT3 | 7473 | PubTator's text mining | https://conductscience.org/library/genes/7473 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17575106
GET https://conductscience.org/api/papers/v1/17575106/cited_by?page=2